Understanding Heart Rate Variability (HRV): What It Reveals About Recovery and the Nervous System in Long COVID, ME/CFS, and POTS
HRV reflects how the autonomic nervous system responds to strain. A factual overview for Long COVID, ME/CFS, and POTS – no medical claims.

Anyone living with Long COVID, ME/CFS, or POTS knows the pattern: a day feels manageable, and the next morning the body feels completely drained. Many people turn to wearables to understand their condition better, and sooner or later they come across a metric called heart rate variability, or HRV. This article explains what HRV actually measures, what current research on post-viral illness and circulatory regulation disorders shows, and how to observe it in a useful, level-headed way.
What HRV measures – and what it doesn't
HRV describes the variation in time intervals between consecutive heartbeats. A well-regulated nervous system continuously adjusts heart rhythm to changing demands, which causes slight beat-to-beat variation. This fine-tuned adaptability is largely governed by the autonomic nervous system, specifically the interplay between its sympathetic ("activating") and parasympathetic ("recovery") branches. Higher HRV is generally considered a sign of flexible, well-balanced regulation, while a persistently low or erratic HRV can point to a shift toward dominant sympathetic activation.
It's worth noting that HRV is a population-level measure, not a single value with a fixed "normal range." It depends on age, sex, fitness, time of day, sleep, stress, caffeine, breathing pattern, and the device used. A single low reading on one morning says little; what matters more is the individual trend over days and weeks compared with one's own baseline.
What the research on Long COVID, ME/CFS, and POTS shows
Several studies in recent years have documented autonomic dysregulation in post-viral conditions. A 48-hour HRV monitoring study in people with ME/CFS and post-COVID syndrome found evidence of altered autonomic balance compared with healthy controls, with differences observed both during the day and during nighttime sleep. Another study on post-COVID-19 syndrome described measurable HRV changes reflecting autonomic dysregulation in a subset of affected individuals.
Particularly relevant for pacing is a 2025 study that used wearable-derived HRV data to identify autonomic abnormalities and possible thresholds related to post-exertional malaise (PEM) in Long COVID. The authors suggest that continuous HRV monitoring could help flag emerging overexertion before a crash is fully underway. In POTS, a systematic review with meta-analysis also found consistent differences in heart rate and HRV compared with healthy comparison groups, contributing to the broader picture of underlying autonomic regulatory disruption.
For context, it matters that these studies describe group-level trends and contribute foundational knowledge – they do not establish a universal HRV threshold that reliably predicts a crash for every individual. Variation between people is substantial, and research into individual early-warning values is still in its early stages.
Observing HRV meaningfully with a wearable
For those who want to use HRV as an additional building block in day-to-day pacing, a few simple principles help:
- Establish a baseline before interpreting: Track morning resting readings for two to three weeks before judging any deviation. Without a personal baseline, a single value is hard to interpret.
- Keep conditions consistent: Readings taken right after waking, lying down, before caffeine, and before physical activity are the most comparable over time.
- Look at trend, not single days: A rolling multi-day average is more informative than any one morning's number, since HRV naturally fluctuates.
- Read it in context: Consider HRV alongside resting heart rate, sleep quality, a symptom log, and subjective energy level rather than relying on one number alone.
- Watch for device consistency: Switching wearables or measurement methods (chest strap versus optical wrist sensor) can shift absolute values considerably – that shift doesn't necessarily reflect a real change in the body.
A sustained low trend, or a clear deviation from one's usual pattern, can – together with other signals such as elevated resting heart rate or disrupted sleep – suggest the body currently has fewer reserves and that more cautious pacing may be warranted. Conversely, a "good" HRV reading never overrides how the body actually feels.
Keeping the limits in view
HRV offers an interesting window into autonomic regulation, but it is not a measure that alone determines capacity. It can be influenced by many factors unrelated to PEM, such as infections, heat, menstrual cycle, sleep deprivation, or emotional strain. The sensor hardware itself does not always deliver clinically validated accuracy. HRV figures from consumer wearables should therefore be understood as an orienting, supplementary signal rather than a substitute for professional evaluation of physical symptoms. Anyone noticing new or worsening symptoms should discuss this with a clinician regardless of what wearable data shows.
Conclusion
Heart rate variability offers people with Long COVID, ME/CFS, and POTS an additional, objective signal for how the autonomic nervous system is responding to demand at a given moment. Current research points to measurable differences from healthy autonomic regulation and suggests that continuous monitoring may help flag overexertion earlier. What matters most day to day is not a single number but the personal trend over time, read alongside sleep, resting heart rate, and how the body actually feels. Used this way, HRV becomes a helpful additional building block for pacing – a point of orientation, not the sole measure.
Sources
- Wearable heart rate variability monitoring identifies autonomic dysfunction and thresholds for post-exertional malaise in Long COVID — medRxiv
- Dysregulation of the autonomic nervous system in ME/CFS and post-COVID syndrome: insights from 48-h heart rate variability monitoring — Journal of the Neurological Sciences
- Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability — Scientific Reports (Nature)
- Pacing with a heart rate monitor to minimize post-exertional malaise (PEM) in ME/CFS and long COVID — Workwell Foundation
- Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis — BMC Cardiovascular Disorders
Two to three weeks of baseline, comparable conditions, a rolling average: that is exactly the arithmetic mypacing takes off your hands. How the values are evaluated — including confidence ranges and what does not yet hold up — is laid out openly on the technology page.
Open the technology page — how mypacing evaluates HRV and heart rate, with all the figures Create an account — free for good, no adsmypacing is also available for your phone. How to set up the Android version is described on the Android page.
How this article came about: the text was drafted by an AI system (an Anthropic model with web search); the sources are real references found while writing, not invented addresses. It appeared after an automatic risk check, without an individual human release — articles about medication, dosage, diagnosis and therapy are excluded from that route and always go to a person. We say this under Art. 50 of the EU AI Act — and because it seems right to say it. More under Legal, Section 4e.